Anuj Patel

Anuj Patel serves as a Contract Specialist within the NIH NIAID DEA OA OFC ACQUISITIONS, supporting the National Institute of Allergy and Infectious Diseases’ mission to advance research on infectious, immunologic, and allergic diseases. In this role, he manages the full lifecycle of complex procurements for high-performance laboratory instrumentation, biotechnological research services, and specialized analytical platforms critical to vaccine development, immune response characterization, and pathogen detection. His expertise lies in structuring competitive solicitations that align with federal acquisition regulations while ensuring technical rigor and scientific relevance, directly enabling NIAID’s cutting-edge research initiatives. While no specific contractor relationships are currently identifiable in the dataset, Patel consistently engages with a broad spectrum of research service providers and technology vendors specializing in life sciences innovation. His procurement approach emphasizes competitive bidding among firms with demonstrated capability in advanced instrumentation, bioanalytical systems, and molecular diagnostics, fostering partnerships with both established scientific contractors and emerging innovators in the bioresearch ecosystem. Patel’s contracting patterns reflect a strong preference for open competition, with 100% of his acquisitions issued without set-aside designations, indicating a focus on technical merit and capability over socioeconomic classifications. This approach prioritizes mission-critical performance and scientific readiness, ensuring access to the most qualified providers regardless of business size or certification status. His procurement activity is heavily concentrated in NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences), accounting for 90% of his portfolio, with an additional 10% in NAICS 541714 (Research and Development in Biotechnology). He routinely acquires next-generation sequencing platforms, flow cytometry systems, high-throughput screening tools, and contract research services for immunology and virology studies, demonstrating deep familiarity with the technical demands of modern biomedical research.